Is Chemed Corp Stock a Good Investment?
Chemed Corp Investment Advice | CHE |
- Examine Chemed Corp's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Chemed Corp's leadership team and their track record. Good management can help Chemed Corp navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Chemed Corp's business and its evolving consumer preferences.
- Compare Chemed Corp's performance and market position to its competitors. Analyze how Chemed Corp is positioned in terms of product offerings, innovation, and market share.
- Check if Chemed Corp pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Chemed Corp's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Chemed Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Chemed Corp is a good investment.
Sell | Buy |
Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Chemed Corp Stock
Researching Chemed Corp's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.39. Chemed Corp recorded earning per share (EPS) of 19.92. The entity last dividend was issued on the 24th of February 2025. The firm had 2:1 split on the 12th of May 2005.
To determine if Chemed Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chemed Corp's research are outlined below:
| Chemed Corp is unlikely to experience financial distress in the next 2 years | |
| Chemed Corp has 140.84 M in debt with debt to equity (D/E) ratio of 0.38, which is OK given its current industry classification. Chemed Corp has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Chemed to invest in growth at high rates of return. | |
| Over 97.0% of Chemed Corp shares are held by institutions such as insurance companies | |
| On 14th of March 2025 Chemed Corp paid $ 0.5 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Disposition of 13620 shares by Nicholas Westfall of Chemed Corp at 586. subject to Rule 16b-3 |
Chemed Corp Quarterly Cost Of Revenue |
|
Chemed Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chemed Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chemed Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Chemed Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Chemed Corp's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2003-02-07 | 2002-12-31 | 0.15 | 0.13 | -0.02 | 13 | ||
2004-05-04 | 2004-03-31 | 0.2 | 0.23 | 0.03 | 15 | ||
1993-10-22 | 1993-09-30 | 0.19 | 0.22 | 0.03 | 15 | ||
1993-04-22 | 1993-03-31 | 0.24 | 0.21 | -0.03 | 12 | ||
2005-03-08 | 2004-12-31 | 0.37 | 0.41 | 0.04 | 10 | ||
2003-10-16 | 2003-09-30 | 0.14 | 0.1 | -0.04 | 28 | ||
1996-07-18 | 1996-06-30 | 0.25 | 0.29 | 0.04 | 16 | ||
2005-05-03 | 2005-03-31 | 0.35 | 0.4 | 0.05 | 14 |
Chemed Corp Target Price Consensus
Chemed target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Chemed Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Chemed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Chemed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Chemed Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationChemed Corp Target Price Projection
Chemed Corp's current and average target prices are 601.61 and 663.67, respectively. The current price of Chemed Corp is the price at which Chemed Corp is currently trading. On the other hand, Chemed Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Chemed Corp Market Quote on 21st of March 2025
Target Price
Analyst Consensus On Chemed Corp Target Price
Chemed Corp Analyst Ratings
Chemed Corp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Chemed Corp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Chemed Corp's financials, market performance, and future outlook by experienced professionals. Chemed Corp's historical ratings below, therefore, can serve as a valuable tool for investors.Know Chemed Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chemed Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemed Corp backward and forwards among themselves. Chemed Corp's institutional investor refers to the entity that pools money to purchase Chemed Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-12-31 | 266.8 K | Td Global Investment Solutions – Td Epoch | 2024-12-31 | 252.2 K | Btim Corp | 2024-12-31 | 242.2 K | Ameriprise Financial Inc | 2024-12-31 | 233.7 K | Northern Trust Corp | 2024-12-31 | 208.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 199.3 K | Amvescap Plc. | 2024-12-31 | 182.1 K | Norges Bank | 2024-12-31 | 181 K | Dekabank Deutsche Girozentrale | 2024-12-31 | 155.3 K | Vanguard Group Inc | 2024-12-31 | 1.7 M | Blackrock Inc | 2024-12-31 | 1.4 M |
Chemed Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 8.81 B.Market Cap |
|
Chemed Corp's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.33 | 0.35 | |
| Return On Capital Employed | 0.27 | 0.14 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 7.62 | 8.00 |
Determining Chemed Corp's profitability involves analyzing its financial statements and using various financial metrics to determine if Chemed Corp is a good buy. For example, gross profit margin measures Chemed Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chemed Corp's profitability and make more informed investment decisions.
Please note, the presentation of Chemed Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemed Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemed Corp's management manipulating its earnings.
Evaluate Chemed Corp's management efficiency
Chemed Corp has Return on Asset of 0.1395 % which means that on every $100 spent on assets, it made $0.1395 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2712 %, implying that it generated $0.2712 on every 100 dollars invested. Chemed Corp's management efficiency ratios could be used to measure how well Chemed Corp manages its routine affairs as well as how well it operates its assets and liabilities. At present, Chemed Corp's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 8.00, whereas Return On Capital Employed is forecasted to decline to 0.14. At present, Chemed Corp's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 196.1 M, whereas Total Current Assets are forecasted to decline to about 198.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 74.48 | 78.20 | |
| Tangible Book Value Per Share | 23.96 | 25.16 | |
| Enterprise Value Over EBITDA | 17.06 | 9.90 | |
| Price Book Value Ratio | 200.77 | 210.81 | |
| Enterprise Value Multiple | 17.06 | 9.90 | |
| Price Fair Value | 200.77 | 210.81 | |
| Enterprise Value | 7.1 B | 7.5 B |
Examining the leadership quality of Chemed Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Basic technical analysis of Chemed Stock
As of the 21st of March, Chemed Corp shows the risk adjusted performance of 0.096, and Mean Deviation of 1.08. Chemed Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Chemed Corp downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Chemed Corp is priced correctly, providing market reflects its regular price of 601.61 per share. Given that Chemed Corp has jensen alpha of 0.201, we suggest you to validate Chemed Corp's prevailing market performance to make sure the company can sustain itself at a future point.Chemed Corp's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemed Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemed Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemed Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chemed Corp's Outstanding Corporate Bonds
Chemed Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemed Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemed bonds can be classified according to their maturity, which is the date when Chemed Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Chemed Corp's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Chemed Corp's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.096 | |||
| Market Risk Adjusted Performance | 0.2314 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 1.12 | |||
| Downside Deviation | 1.32 | |||
| Coefficient Of Variation | 967.46 | |||
| Standard Deviation | 1.55 | |||
| Variance | 2.4 | |||
| Information Ratio | 0.1452 | |||
| Jensen Alpha | 0.201 | |||
| Total Risk Alpha | 0.281 | |||
| Sortino Ratio | 0.1703 | |||
| Treynor Ratio | 0.2214 | |||
| Maximum Drawdown | 8.98 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 2.33 | |||
| Downside Variance | 1.75 | |||
| Semi Variance | 1.25 | |||
| Expected Short fall | (1.08) | |||
| Skewness | 1.68 | |||
| Kurtosis | 6.63 |
| Risk Adjusted Performance | 0.096 | |||
| Market Risk Adjusted Performance | 0.2314 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 1.12 | |||
| Downside Deviation | 1.32 | |||
| Coefficient Of Variation | 967.46 | |||
| Standard Deviation | 1.55 | |||
| Variance | 2.4 | |||
| Information Ratio | 0.1452 | |||
| Jensen Alpha | 0.201 | |||
| Total Risk Alpha | 0.281 | |||
| Sortino Ratio | 0.1703 | |||
| Treynor Ratio | 0.2214 | |||
| Maximum Drawdown | 8.98 | |||
| Value At Risk | (1.72) | |||
| Potential Upside | 2.33 | |||
| Downside Variance | 1.75 | |||
| Semi Variance | 1.25 | |||
| Expected Short fall | (1.08) | |||
| Skewness | 1.68 | |||
| Kurtosis | 6.63 |
Consider Chemed Corp's intraday indicators
Chemed Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chemed Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 601.61 | |||
| Day Typical Price | 601.61 |
Chemed Corp Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 20th of December 2024 Other Reports | ViewVerify |
Chemed Stock media impact
Far too much social signal, news, headlines, and media speculation about Chemed Corp that are available to investors today. That information is available publicly through Chemed media outlets and privately through word of mouth or via Chemed internal channels. However, regardless of the origin, that massive amount of Chemed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chemed Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chemed Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chemed Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chemed Corp alpha.
Chemed Corp Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Chemed Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Chemed Corp Historical Investor Sentiment
Investor biases related to Chemed Corp's public news can be used to forecast risks associated with an investment in Chemed. The trend in average sentiment can be used to explain how an investor holding Chemed can time the market purely based on public headlines and social activities around Chemed Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Chemed Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Chemed Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Chemed Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Chemed Corp.
Chemed Corp Maximum Pain Price Across June 20th 2025 Option Contracts
Chemed Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Chemed Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Chemed Corp's options.
Chemed Corp Corporate Directors
| Andrea Lindell | Independent Director | Profile | |
| Thomas Rice | Independent Director | Profile | |
| Joel Gemunder | Independent Director | Profile | |
| Patrick Grace | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.021 | Dividend Share 1.8 | Earnings Share 19.92 | Revenue Per Share | Quarterly Revenue Growth 0.092 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Chemed Corp's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.